AJP - GI Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 288: G1252-G1258, 2005. First published January 13, 2005; doi:10.1152/ajpgi.00362.2004
0193-1857/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/6/G1252    most recent
00362.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chandra, P.
Right arrow Articles by Brouwer, K. L. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chandra, P.
Right arrow Articles by Brouwer, K. L. R.

LIVER AND BILIARY TRACT

Short-term regulation of multidrug resistance-associated protein 3 in rat and human hepatocytes

Priyamvada Chandra, Peijin Zhang, and Kim L. R. Brouwer

School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

Submitted 11 August 2004 ; accepted in final form 10 January 2005

The short-term regulation of multidrug resistance-associated protein 3 (Mrp3/MRP3) by cAMP and PKC was investigated in sandwich-cultured rat and human hepatocytes and isolated perfused rat livers. The modulator glucagon (500 nM) and the phorbol ester PMA (0.1 µM) were utilized to increase intracellular cAMP and PKC levels, respectively. In glucagon-treated rat hepatocytes, efflux of the Mrp3 substrate 5-(6)-carboxy-2',7'-dichlorofluorescein (CDF) increased ~1.5-fold, even in hepatocytes treated with the organic anion transporter (Oatp) inhibitor sulfobromophthalein (BSP). Confocal microscopy revealed more concentrated Mrp3 fluorescence in the basolateral membrane (less diffuse staining pattern) with glucagon treatment. PMA had no effect on Mrp3 activity or localization in sandwich-cultured rat hepatocytes. Glucagon and PMA treatment in isolated perfused rat livers resulted in a threefold increase (14 ± 4.6 µl·min–1·g liver–1) and a fourfold decrease (1.3 ± 0.3 µl·min–1·g liver–1) in CDF basolateral clearance compared with control livers (4.7 ± 2.3 µl·min–1·g liver–1), whereas CDF biliary clearance was not statistically different. In sandwich-cultured human hepatocytes, glucagon treatment resulted in a 1.3-fold increase in CDF efflux and a concomitant increase in MRP3 fluorescence in the basolateral membrane. In summary, cAMP and PKC appear to be involved in the short-term regulation of Mrp3/MRP3, as demonstrated by alterations in activity and localization in rat and human hepatocytes.

transport; 5-(6)-carboxy-2',7'-dichlorofluorescein; sandwich culture; glucagon; phorbol ester



Address for reprint requests and other correspondence: K. L. R. Brouwer, 3205 Kerr Hall, CB #7360, School of Pharmacy, Univ. of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7360 (E-mail: kbrouwer{at}unc.edu)




This article has been cited by other articles:


Home page
Toxicol SciHome page
K. Letschert, H. Faulstich, D. Keller, and D. Keppler
Molecular Characterization and Inhibition of Amanitin Uptake into Human Hepatocytes
Toxicol. Sci., May 1, 2006; 91(1): 140 - 149.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.